Company Description
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
This segment also offers consultation services to clients throughout their experimental design and implementation processes.
The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 1978 |
| IPO Date | Feb 1, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | John P. Marotta |
Contact Details
Address: 200 Summit Drive, 6th Floor Burlington, Massachusetts 01803 United States | |
| Phone | 888 229 3682 |
| Website | azenta.com |
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| Employer ID | 04-3040660 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Luc Provost | Vice President and Chief Executive Officer of B Medical Systems |
| John P. Marotta | President, Chief Executive Officer and Director |
| Lawrence Y. Lin | Executive Vice President and Chief Financial Officer |
| Ephraim Starr | Senior Vice President, General Counsel and Corporate Secretary |
| Olga Pirogova | Senior Vice President and Chief Human Resources Officer |
| Dr. Ginger Zhou Ph.D. | Senior Vice President and President of GENEWIZ |
| Michael Paulo | Vice President, Chief Information and Digital Officer |
| Yvonne Perron | Vice President of Financial Planning and Analysis and Investor Relations |
| J. Robert Woodward | Senior Vice President of Global Quality and Engineering |
| Dr. Andrea O'Hara Ph.D. | Strategic Technical Specialist of Azenta Life Sciences |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 29, 2025 | 8-K | Current Report |
| Dec 19, 2025 | DEFR14A | Filing |
| Dec 19, 2025 | ARS | Filing |
| Dec 18, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 18, 2025 | DEF 14A | Other definitive proxy statements |
| Dec 10, 2025 | 8-K | Current Report |
| Dec 4, 2025 | 10-K | Annual Report |
| Dec 2, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Nov 21, 2025 | 8-K | Current Report |
| Aug 6, 2025 | 10-Q | Quarterly Report |